Neurocrine Biosciences (NBIX) Short term Debt (2018 - 2024)
Neurocrine Biosciences (NBIX) posted quarterly Short term Debt of $122.8 million for Q1 2024, down 27.81% on a QoQ basis from $170.1 million in Q4 2023.
Neurocrine Biosciences (NBIX) Short term Debt (2018 - 2024) Analysis & Trends
Neurocrine Biosciences has reported Short term Debt for 6 years, with the latest figure at $122.8 million in Q1 2024.
- Short term Debt for Q1 2024 came in at $122.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $122.8 million (changed N/A YoY), and the FY2023 annual result was $170.1 million, changed 0.41% from the prior year.
- Short term Debt eased to $122.8 million in Q1 2024, from $170.1 million in the prior quarter.
- Over five years, Short term Debt peaked at $425.0 million in Q3 2020 and troughed at $122.8 million in Q1 2024.
- A 4-year average of $227.0 million and a median of $169.8 million in 2023 frame the typical range for Short term Debt.
- The largest YoY upside for Short term Debt was 0.41% in 2023 against a maximum downside of 0.41% in 2023.
- A 4-year view of Short term Debt shows it stood at $425.0 million in 2020, then tumbled by 60.14% to $169.4 million in 2022, then rose by 0.41% to $170.1 million in 2023, then declined by 27.81% to $122.8 million in 2024.
- Per Business Quant data, the three most recent Short term Debt figures were $122.8 million in Q1 2024, $170.1 million in Q4 2023, and $169.9 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 122.80 Mn |
| Dec 31, 2023 | 170.10 Mn |
| Sep 30, 2023 | 169.90 Mn |
| Jun 30, 2023 | 169.70 Mn |
| Dec 31, 2022 | 169.40 Mn |
| Sep 30, 2022 | 169.20 Mn |
| Sep 30, 2020 | 425.00 Mn |
| Jun 30, 2020 | 419.50 Mn |
| Dec 31, 2019 | 408.80 Mn |
| Sep 30, 2018 | 383.65 Mn |